Ligand validation:7EMO

NHE: 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7EMO_NHE_C_204	71%	9%	0.088	0.908	2.66	1.79	2	3	0	0	100%	1
7EMO_NHE_C_205	46%	10%	0.166	0.9	2.18	2.15	2	2	0	0	100%	1
7EMO_NHE_B_202	26%	7%	0.162	0.803	2.54	2.2	2	4	0	0	100%	1
7EMP_NHE_A_202	85%	10%	0.079	0.942	2.78	1.63	2	3	0	0	100%	1
7EMR_NHE_A_202	79%	10%	0.088	0.934	2.79	1.54	2	2	0	0	100%	1
7EMQ_NHE_C_202	78%	9%	0.086	0.929	2.3	2.11	2	4	0	0	100%	1
5TSP_NHE_A_1001	99%	51%	0.053	0.99	0.93	0.98	-	1	0	0	100%	1
3WXP_NHE_A_404	99%	10%	0.052	0.986	1.81	2.52	4	7	0	0	100%	0.94
2DSY_NHE_C_1001	99%	34%	0.051	0.979	1.49	1.14	1	1	0	0	100%	1
3WH6_NHE_A_505	99%	13%	0.056	0.984	1.25	2.71	2	5	0	0	100%	1
3O1W_NHE_B_488	98%	17%	0.063	0.985	1.36	2.21	1	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.